期刊文献+

UGT1A1*28基因多态性在68例小细胞肺癌中的分布

Distribution of UGT1A1 * 28 polymorphism in 68 patients with small cell lung cancer
原文传递
导出
摘要 目的 测定68例小细胞肺癌中UGT1A1* 28基因多态性的频率与分布情况.方法 收集中南大学湘雅医院68例中国人小细胞肺癌患者和33名中国正常人外周血标本,抽提基因组DNA,PCR法扩增目的基因片段,荧光标记测序法测定UGT1A1基因启动子区TATA盒胸腺嘧啶-腺嘌呤(TA)序列重复次数,统计中国小细胞肺癌和正常人中UGT1A1* 28基因多态性分布情况.结果 68例小细胞肺癌患者中51例(75.00%)为(TA) 6/(TA)6型,17例(25.00%)为(TA) 6/(TA)7型,0例为(TA)7/(TA)7型;33名正常人中25名(75.76%)为(TA) 6/(TA)6型,6名(18.18%)为(TA)6/(TA)7型,2名(6.06%)为(TA)7/(TA)7型.结论 UGT1A1* 28基因多态性在中国小细胞肺癌与正常人群中的分布有统计学差异.中国人UGT1A1* 28基因多态性发生频率与欧美人群有较大区别. Objective To determine the frequency and distribution of UGT1A1 * 28 polymorphism in 68 patients with small cell lung cancer in China.Methods Peripheral blood samples were collected from 68 cases of small cell lung cancer and 33 normal persons.Genomic DNA was extracted from the patients leukocytes in the peripheral blood.Then the target gene fragment was amplified by PCR and the genotypes were determined by analyzing the sequence of TATA boxes in the UGT1A1 gene by fluorescently labeled sequencing method.The frequency and distribution of UGT1A1 * 28 polymorphism in patients with small cell lung cancer and normal persons in China were analyzed.Results In 68 cases of small cell lung cancer:51 patients (75.00%) with (TA)6/(TA)6 genotype,17 patients (25.00%) with (TA)6/(TA)7 genotype,nopatients with (TA)7/(TA)7 genotype;in 33 normal persons:25 persons (75.76%) with (TA)6/(TA)6 genotype,six persons (18.18%) with (TA) 6/(TA) 7 genotype,two persons (6.06%) with (TA)7/(TA)7 genotype.Conclusions There is significant difference on the distribution of UGT1A1 * 28 polymorphism in patients with small cell lung cancer and normal population in China.The incidence of UGT1A1 * 28 polymorphism in China is significantly different from European and American.
出处 《国际呼吸杂志》 2014年第12期926-930,共5页 International Journal of Respiration
关键词 UGT1A1 小细胞肺癌 基因多态性 UGT1A1 Small cell lung cancer Gene polymorphism
  • 相关文献

参考文献4

二级参考文献18

  • 1王融冰,周桂琴,江宇泳,孙凤霞,吴云忠,孙静媛,孟培培,牛思盟.799例重型肝炎患者的临床病原学与实验室分析[J].中华肝脏病杂志,2006,14(9):655-657. 被引量:57
  • 2吴殿磊,徐光华,冯继红,樊霞,苗乃周,刘晓斌,陈天艳,张树林.二十岁以下慢性HBV感染者HBV DNA与HBeAg的定量关系[J].世界华人消化杂志,2007,15(8):909-912. 被引量:9
  • 3马慧,郭芳,魏来,孙焱,王豪.HBeAg阴性和HBeAg阳性乙型肝炎肝硬化患者临床特征及预后的前瞻性研究[J].中华医学杂志,2007,87(26):1832-1835. 被引量:9
  • 4吴伯祥,郭丽芳,刘明亮.e抗原阴性患者抗病毒治疗中乙型肝炎前S1抗原的变化[J].胃肠病学和肝病学杂志,2007,16(5):412-413. 被引量:4
  • 5National Cancer Institute.Common Terminology Criteria for Adverse Events V3.0. http://ctep.cancer.gov/protocol Development/electronic_applications/docs/ctcaev3.pdf .
  • 6Rouits E,Charasson V,Pétain A,et al.Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer pa-tients[].British Journal of Cancer.2008
  • 7Chabot,GG.Clinical pharmacokinetics of irinotecan[].Clinical Pharmacokinetics.1997
  • 8F Innocenti,SD Undevia,L Iyer,PX Chen,S Das,M Kocherginsky,T Karrison,L Janisch,J Ramirez,CM Rudin,EE Vokes,MJ Ratain.Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan[].Clinical Oncology.2004
  • 9Ando Y,Saka H,Ando M,et al.Polymorphisms of UDPglucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis[].Cancer Research.2000
  • 10Massacesi C,Terrazzino S,Marcucci F,et al.Uridine diphos-phate glucuronosyl transferase 1A1 promoter polymorphism pre-dicts the risk of gastrointestinal toxicity and fatigue induced by iri-notecan-based chemotherapy[].Cancer.2006

共引文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部